Lpath, Inc. (LPTN) - Financial and Strategic SWOT Analysis Review

Lpath, Inc. (LPTN) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Lpath, Inc. (Lpath) discovers and develops monoclonal antibodies that target bioactive lipids. It develops lipidomic-based therapeutic antibodies that target bioactive signaling lipids to treat a wide range of human diseases. The company’s pipeline product candidates include iSONEP, indicated for age-related macular degeneration (AMD), retinal pigment epithelium (RPE) detachment and other retinal diseases; ASONEP indicated for various types of cancer; and Lpathomab indicated for fibrosis, spinal cord injury, traumatic brain injury, neuropathic pain and cancer. The company's proprietary platform technology is applied in various therapeutic areas such as cancer, pain, asthma, inflammation, sepsis and others. Lpath is headquartered in San Diego, California, the US.

Lpath, Inc. Key Recent Developments

Sep 29, 2015: Lpath Appoints Gary Atkinson Interim Chief Executive Officer

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Section 1 - About the Company
Lpath, Inc. - Key Facts
Lpath, Inc. - Key Employees
Lpath, Inc. - Key Employee Biographies
Lpath, Inc. - Major Products and Services
Lpath, Inc. - History
Lpath, Inc. - Company Statement
Lpath, Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Lpath, Inc. - Business Description
Lpath, Inc. - Corporate Strategy
Lpath, Inc. - SWOT Analysis
SWOT Analysis - Overview
Lpath, Inc. - Strengths
Strength - Focused R&D Activities
Strength - Unique Technology Platform: ImmuneY2
Strength - Licensing Agreements
Lpath, Inc. - Weaknesses
Weakness - Lack of Commercialized Products
Weakness - Decline in Cash Reserves
Lpath, Inc. - Opportunities
Opportunity - Changing Demographics
Opportunity - Agreement with Pfizer
Opportunity - Lipidomic-based Product Pipeline
Lpath, Inc. - Threats
Threat - Dependence on Third Parties
Threat - Intense Competition
Threat - Tightening of the FDA’s Regulatory Oversight
Lpath, Inc. - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Lpath, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Lpath, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Lpath, Inc., Recent Deals Summary
Section 5 – Company’s Recent Developments
Sep 29, 2015: Lpath Appoints Gary Atkinson Interim Chief Executive Officer
Section 6 – Appendix
Ratio Definitions
About GlobalData
Contact Us
List of Tables
Lpath, Inc., Key Facts
Lpath, Inc., Key Employees
Lpath, Inc., Key Employee Biographies
Lpath, Inc., Major Products and Services
Lpath, Inc., History
Lpath, Inc., Subsidiaries
Lpath, Inc., Key Competitors
Lpath, Inc., Ratios based on current share price
Lpath, Inc., Annual Ratios
Lpath, Inc., Interim Ratios
Lpath, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Lpath, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Lpath, Inc., Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Lpath, Inc., Performance Chart (2011 - 2015)
Lpath, Inc., Ratio Charts
Lpath, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Lpath, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook